** Shares of biotech firm BNTC.O fall ~38% to hit a record
low of $2.98 and are on pace for their worst day ever
** BNTC is among biggest pct losers across U.S. stocks
** Company prices offering of 3.2 mln shares at $3.10
apiece, which implies a ~35% discount to stock's last close
** Offer size represents ~400% of co's free float, according
to Refinitiv data
** BNTC to use proceeds of about $10 mln for the advancement
of development activities for its product pipeline, among other
things urn:newsml:reuters.com:*:nPn195nNMa
** H.C. Wainwright & Co is the sole bookrunning manager of
the offering
** Stock is down ~61% YTD
(Reporting by Abhishek Manikandan in Bengaluru)
((Abhishek.Manikandan@thomsonreuters.com))